In patients with COVID-19, higher serum C-reactive protein, interleukin-6, and LDH levels, which correlated with disease severity, were observed in the diabetic group with hyperglycemia than in the non-diabetic group [6, 25]. The gene discussed is IL6; the disease is COVID-19.